Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,005.76 -65.87 (-1.30%) Dow
37,897.02 -563.90 (-1.47%) Nasdaq
15,420.99 -291.76 (-1.86%) Bitcoin USD
63,441.25 -2,707.61 (-4.09%) CMC Crypto 200
1,346.89 -35.68 (-2.58%)
GILD Jan 2025 77.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:39PM EDT. Market open.
| Previous close | 2.1400 |
| Open | 1.9900 |
| Bid | 1.7500 |
| Ask | 2.6500 |
| Strike | 77.50 |
| Expiry date | 2025-01-17 |
| Day's range | 1.9900 - 2.1400 |
| Contract range | N/A |
| Volume | |
| Open interest | 682 |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
© 2024 Yahoo. All rights reserved.